Nevertheless, our findings also imply its antimetastatic character in BRAF-mutated cells, indicating that the expressional status and functions of FRMD5 may not be dependent on the type of cancer tissue but rather on genetic alternations in cancer cells. Here, BRAF is linked to cancer.